世界中で特に引用数の多い論文

Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases: a potential surrogate endpoint for time to surgical failure
Ann Surg Oncol 2014; 21: 1817-1824.
論文ファイル
Survival benefit of repeat resection of successive recurrences after the initial hepatic resection for colorectal liver metastases
Surgery 2016; 159: 632-640.
論文ファイル

その他主な英語論文

Adjuvant chemotherapy can prolong recurrence-free survival but did not influence the type of recurrence or subsequent treatment in patients with colorectal liver metastases
Surgery 2021; DOI:https://doi.org/10.1016/j.surg.2021.04.012
A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)
Ann Surg Oncol 2020; 27: 4188-4195.
Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial
PLoS One 2016; 11: e0162400.
Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases
Invest New Drugs 2016; 34: 468-473.
CD133 Expression at the Metastatic Site Predicts Patients’ Outcome in Colorectal Cancer with Synchronous Liver Metastasis
Ann Surg Oncol 2016; 23: 1916-1923.
Repeat resection leads to long-term survival: analysis of 10-year follow-up of patients with colorectal liver metastases
Am J Surg 2015; 210: 904-910.
Radiological Morphology of Colorectal Liver Metastases after Preoperative Chemotherapy Predicts Tumor Viability and Postoperative Outcomes
J Gastrointest Surg 2015; 19: 1653-1661.
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival
Mol Clin Oncol 2015; 3: 1053-1057.
Cetuximab for resectable colorectal liver metastasis: new EPOC trial
Lancet Oncol 2014; 15: e305-306.
Evaluation of the safety and efficacy of simultaneous resection of primary colorectal cancer and synchronous colorectal liver metastases
Surgery 2014; 155: 478-485.
Surgical resection for local recurrence after radiofrequency ablation for colorectal liver metastasis is more extensive than primary resection
Scand J Gastroenterol 2014; 49: 569-575.
A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study
Drug Discov Ther 2014; 8: 48-56.
Perioperative chemotherapy and liver resection for hepatic metastases of colorectal cancer
J Hepatobiliary Pancreat Sci 2012;19: 503-508.
Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
Breast Cancer 2011; 18: 195-202.
Availability of irinotecan in a second-line setting confers survival benefit to patients with advanced gastric cancer refractory to fluoropyrimidine-based regimens
Oncol Lett 2011; 2: 247-251.
Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens
Oncol Lett 2011; 2: 241-245.
A case of lymphocytic mastopathy requiring differential diagnosis from primary breast lymphoma
Breast Cancer 2009; 16: 141-146.
A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats
Cancer 2009; 115: 454-464.
Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor
Int J Cancer 2008; 123: 1491-1498.